Clinical Trial Update: Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts

View source ↗

Summary

A clinical-trial update describing a study of burosumab with 1-25-dihydroxy vitamin D on human osteoblasts, with recruitment ongoing for craniosynostosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniosynostosis

Drugs mentioned

• Calcitriol (calcitriol)
• Crysvita (burosumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Craniosynostoses | Status: RECRUITING